MaxQ AI Launches ACCIPIO Ax, Slice-ICH Detection and Preview in the US and EU, the Latest Enhancement of the ACCIPIO ICH Platform

ACCIPIO Ax Includes the SliceMap and Slice-Level Preview to Facilitate Rapid Intracranial Hemorrhage Detection and Efficient Clinical Workflow

MaxQ AI, the leading Medical diagnostic AI company, announced that ACCIPIO Ax will begin shipping in August and will be available as a part of the ACCIPIO ICH Platform. ACCIPIO Ax will be the second component of the ACCIPIO ICH Platform and will provide new tools to support clinical assessment of intracranial hemorrhage (ICH).  Radiology Departments, Emergency Room and Neuroradiology teams across the U.S. and the EU will soon be able to access a comprehensive solution for ICH triage through workflow prioritization and slice-level preview. ACCIPIO Ax includes the exclusive ACCIPIO Ax SliceMap, an integrated view which guides clinicians rapidly to CT slices with suspected ICH without leaving their PACS viewer.

“Healthcare today is under a level of pressure that is unprecedented, and medical diagnostic AI solutions that augment the caregiver are poised to drive an evolution that will deliver significant quality, clinical and economic advancement,” said Gene Saragnese, CEO of MaxQ AI. “The launch of ACCIPIO Ax is significant as it expands our ACCIPIO ICH Platform. This complete solution is designed to deliver answers – instead of more data and analysis – to physicians while seamlessly integrating into their current workflow. With our unmatched partnerships and completed integration – including with GE, IBM, Samsung and TeraRecon – MaxQ AI is well positioned to rapidly deploy our solutions globally.”

Read More: AiThority Interview Series with Anil Kaul, CEO at Absolutdata

With regulatory approvals and an FDA Breakthrough Device designation for ACCIPIO Dx – MaxQ AI’s ACCIPIO suite of software promises to be Seamless from the Start™ with a fully-automated and integrated solution by major OEM CT, PACS and AI ecosystem partners. With the potential for improving detection and workflow for suspected ICH, these solutions are poised to usher in a new era of augmented care by enabling faster and more accurate treatment of patients.

“Each month ACCIPIO® Ix processes nearly one-thousand head CT scans, including upwards of 30 stroke cases per week, at Capital Health,” said Ajay Choudhri, M.D., Chairman of the Department of Radiology at Capital Health Hospitals in New Jersey. “With ACCIPIO Ax, we can now benefit from a comprehensive solution for triage through workflow prioritization and slice-level preview of ICH, including the exclusive ACCIPIO Ax SliceMap, which guides users rapidly to CT images with suspected ICH.”

Read More: AiThority Interview Series With Tom Livne, CEO & Founder, Verbit

With less money than ever before and a shortage of healthcare providers attempting to serve a growing number of patients, Medical Diagnostic AI solutions have the potential to fill a critical void within the healthcare system. It is projected that there will be 3.4 million stroke victims by 2030, which will cause loss or extreme hardships for patients and their families while generating $240 billion in total direct and indirect costs.

The ACCIPIO ICH Platform, the complete ICH solution for stroke and head trauma assessment, promises to help address this by greatly increasing intracranial hemorrhage (ICH) detection and reducing missed ICH through near real-time triage, annotation and diagnostic rule-out.

MaxQ AI is demonstrating the full suite of ACCIPIO ICH Platform solutions during the 57th American Society of Neuroradiology (ASNR) Annual Meeting at the Hynes Convention Center in Boston (May 18-23 at Booth #610).

 Read More: AiThority Interview with Gene Saragnese, CEO, MaxQ AI